Liquid pasteurization of immunoglobulins without stabilizer.
Explore the source record for details and available documents.
Biomedical subjects
Publications and source records attributed to A A Magnin.
Explore the source record for details and available documents.
A clinical trial of a Canadian preparation of antihemophilic factor has been completed. The mean percentage increase in the factor VIII coagulant activity in the plasma was determined to be 2.1 +/- 0.8 per unit per kilogram dose, which compares very favourably with published data. The mean half-life of antihemophilic factor was found to be 14.7 hours. Side effects and reactions to the product were minimal and the product has been rated as clinically effective. No significant differences between lots were noted in the in vivo response or the half-life.
Explore the source record for details and available documents.